Walter Curran Named Emory School of Medicine Radiation Oncology Chair and Emory Winship Cancer Institute Chief Medical Officer
Thomas Lawley, MD, Dean of the Emory University School of Medicine, and Brian Leyland-Jones, MD, PhD, Director of the Winship Cancer Institute, announced today the appointment of Walter Curran, MD, FACR, as professor and chair of the Department of Radiation Oncology in the Emory School of Medicine and as chief medical officer of the Winship Cancer Institute.
Dr. Curran joins Emory from the Jefferson Medical College at Thomas Jefferson University in Philadelphia, where he served as professor and chair of the Department of Radiation Oncology at Jefferson Medical College and clinical director for the Kimmel Cancer Center, also at Jefferson.
“Dr. Curran is one of this nation’s most respected radiation oncologists,” says Dr. Lawley. “We are extremely pleased he is joining our team at Emory. Dr. Curran’s work has advanced the body of knowledge in the treatment of aerodigestive and neurologic malignancies. His intellectual drive combined with his compassion and focus on patient care makes him a wonderful fit for Emory's School of Medicine and the Winship Cancer Institute.”
Dr. Curran has been a principal investigator on numerous groundbreaking National Cancer Institute grants, and he is a sought-after speaker in this country and abroad. He has authored or co-authored more than two hundred abstracts and scholarly papers, as well as several dozen presentations, reviews and book chapters. He is chair or co-chair of approximately 19 clinical protocols and a reviewer for 12 national and international journals.
“Dr. Curran is one of this nation’s preeminent radiation oncologists,” says Dr. Leyland-Jones. “He recognizes the tremendous potential that is here at this stage of Winship’s growth, and we are fortunate to have him join us. In addition, Dr. Curran completes the strong leadership team that we currently have in cancer treatment and research with Dr. Fadlo Khuri in adult Hematology and Oncology, Dr. William Woods in Pediatric Hematology and Oncology, and Dr. William Wood in the Department of Surgery, all in the School of Medicine; and with Dr. Jack Mandel in the Rollins School of Public Health. Dr. Curran’s recruitment is a major boost to Winship’s ongoing drive to NCI Comprehensive Cancer Center designation.”
Dr. Curran currently is the group chairman and principal investigator of the Radiation Therapy Oncology Group, a National Cancer Institute-funded international, multi-institutional cooperative group dedicated to advancing patient treatment and care through cooperative clinical trials and research. He will continue to serve in this role after assuming his responsibilities at Emory.
“Winship’s unique capacity in translational cancer medicine and clinical trials provides a perfect complement to Dr. Curran’s chairmanship of RTOG,” says Dr. Leyland-Jones. Dr. Curran previously served as chairman of the RTOG Brain Tumor Committee.
Dr. Curran is a Fellow in the American College of Radiology and holds honorary memberships in the European Society of Therapeutic Radiology and Oncology and the Canadian Association of Radiation Oncology. In 2006, he was named the leading radiation oncologist/cancer researcher in a peer survey by the journal Medical Imaging. Dr. Curran served for 10 years as the Group Chair of the Radiation Therapy Oncology Group, a national, multi-institutional cooperative group dedicated to advancing patient treatment and care through cooperative clinical trials and research. He also served as chair of the RTOG Brain Tumor Committee.
“I am looking forward to working with the tremendous faculty and staff at Emory,” says Dr. Curran. “This is an exciting time in the field of cancer research and treatment, and Emory is leading the way in many are as of research and patient care.”
Dr. Curran graduated cum laude from Dartmouth College, received his MD degr ee from the Medical College of Georgia, and is a Board Certified Radiation Oncologist. Dr. Curran completed his residency in the Department of Radiation Therapy at the University of Pennsylvania Medical Center and his internship in internal medicine at Presbyterian Medical Center in Philadelphia.